The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

Many antibiotic labels contain warnings not to take them with alcohol. Learn more about the risks of drinking while taking ...

A man who has admitted supplying class A drugs on the streets of Norfolk has been warned jail is “highly likely”. Gytis Volskis, of King Street, Great Yarmouth, was charged with two counts of ...

A MAN from Nomansland has been charged following a huge drugs bust which saw thousands of suspected Class A drugs seized by police. Two men have been charged and three more people arrested after ...

A Swindon man has been jailed for five years after he was arrested with £52,000 worth of drugs. Jake Bell, of Eglantyne Avenue in Tadpole Garden Village, pleaded guilty to possession with intent ...

The official order reads: “All Heads of Schools of Govt., Govt. Aided, Unaided Recognized Private Schools of DOE, NDMC, MCD, and Delhi Cantonment Board are directed to conduct classes in schools for ...

First-in-class drugs are therapies that utilize novel mechanisms of action, offering new approaches to challenging diseases. In 2024, the U.S. Food and Drug Administration (FDA) approved 50 new ...

"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...